Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Snap and speak: new study tests voice and face screening for allergies

NCT ID NCT06474923

Diagnosis Sponsor: Zheng Liu Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 26, 2026 · Last updated Jun 26, 2026

Summary

This completed study tested whether facial images and voice recordings can help screen for allergic rhinitis (hay fever). Researchers collected photos and voice samples from 1500 people with chronic rhinitis, then compared them to standard allergy tests. The goal was to build a prediction model that could identify allergic rhinitis without invasive procedures.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

What this could lead to
If successful, this could lead to a quick, non-invasive screening tool for allergic rhinitis using just a photo and voice recording.
What could go wrong
This is a completed observational study, so it shows feasibility but not proof of effectiveness in real-world settings. The model may not work well outside the study population.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

1,500 people

The number who actually took part.

Started

Jun 2024

Finished

Jun 2025

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

Initial clinical diagnosis of chronic rhinitis, able to perform a basic examination, cooperate with face photography and voice capture

Ages

8 to 80 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: 1. Subjects understood the purpose and procedure of the trial and signed an informed consent form, and voluntarily participated in this study; 2. Subjects were initially clinically diagnosed with chronic rhinitis; 3. Subjects were aged 8-80 years old, limited to Chinese nationality, and were able to perform basic examinations and cooperate with face photography and voice collection. Exclusion Criteria: 1. Those who received systemic immunotherapy, used systemic or local glucocorticoids as well as leukotriene receptor antagonists within one month; 2. Those who suffer from immune system diseases, autoimmune diseases, allergic diseases or allergies and have a history of food allergy; 3. Other serious systemic diseases, such as active tuberculosis, rheumatic heart disease, congenital heart disease, arthritis, nephritis, hypertension, psychosis, dermatitis, epilepsy and so on; 4. Women during lactation and pregnancy; 5. History of upper respiratory tract infection or more serious infectious diseases within three months; 6. Those who are currently participating in another clinical study or have participated in another clinical study within 90 days; 7. Other patients who, in the judgment of the clinician, are not suitable for inclusion in the study.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Body image are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

chronic rhinitis Speech Sound Disorder speech-sound disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Body image Speech sound disorder

Contacts and locations

Locations

  • Professor of Otolaryngology-Head & Neck Surgery Vice Director Department of ENT Tongji Hospital Tongji Medical College Huazhong University of Science and Technology Affiliation: Huazhong University of Science and Technology

    Wuhan, Hubei, 430030, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.